doi: 10.3389/fendo.2024.1366940 Received 07 January 2024 Accepted 28 March 2024 Published 11 April 2024 Volume 15 - 2024 Edited by Ozlem Celik, Acbadem University, Trkiye Reviewed by Heather Caslin, University of Houston, United States Meral Mert, Bakrky Dr
This FDA-approved treatment offers a dual-action approach, using GLP-1 and GIP receptor agonists to effectively reduce appetite, slow down digestion, and improve blood sugar control
L-carnitine nanoparticle treatment improves sperm parameters Upon exposure to CYP, there were a substantial reduction ( P 0.05) in sperm parameters, including their motility, count, and viability, and an increase ( P 0.05) in sperm morphological deformity
The amounts of p -nitroaniline released from -glutamyl- p -nitroanilide in assays using crude protein extracts from yeast expressing AsGGT1, AsGGT2, and AsGGT3, respectively, were significantly higher than that in assays using crude protein extracts from control yeast ( Table 1 ), indicating that the recombinant proteins of AsGGT1, AsGGT2, and AsGGT3 were successfully expressed and folded to form mature functional GGT proteins that can utilize -glutamyl- p -nitroanilide as a -glutamyl donor substrate in yeast cells
